SNOA — Sonoma Pharmaceuticals, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1367083 ·
Last close
$1.27
Market Cap
$6.08M
52W High
$4.60
52W Low
$0.85
ADV30
65,487
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 6,406,000 | 2,577,000 | -40,000 | -330,000 | 18,107,000 | 5,338,000 | 11,513,000 |
| Mar 2026 | 5,561,000 | 2,181,000 | -351,000 | -581,000 | 13,960,000 | 2,399,000 | 10,865,000 |
| Dec 2025 | 4,349,000 | 1,650,000 | -678,000 | -819,000 | 13,623,000 | 2,561,000 | 10,191,000 |
| Sep 2025 | 5,604,000 | 2,120,000 | -337,000 | -534,000 | 13,856,000 | 3,035,000 | 10,069,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-2,567,000
Investing CF
$-88,000
Financing CF
$3,989,000
CapEx
$-88,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-1.65
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-201,311,000
Inventory
$3,786,000
Receivables
$3,182,000
ST Investments
—
EBIT TTM
$-1,406,000
Pretax Income TTM
$-2,507,000
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$21,920,000
EBITDA
$-1,271,000
Free Cash Flow
$-1,469,750
Enterprise Value
$1,649,894
Total Cash
$5,338,000
Total Debt
$739,000
Shares Out
4,788,425
Trailing EPS
$-1.22
Book Value
$1.72
ROE
-42.5%
ROA
-5.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 19,529,000 | -2,461,000 | -3,175,000 | 13,960,000 | 10,865,000 | 3,095,000 | -3,933,000 |
| Mar 2025 | 14,288,000 | -3,710,000 | -3,457,000 | 13,693,000 | 9,282,000 | 4,411,000 | -88,000 |
| Mar 2024 | 12,735,000 | -4,701,000 | -4,835,000 | 14,740,000 | 8,603,000 | 6,137,000 | -2,398,000 |
| Mar 2023 | 13,272,000 | -4,570,000 | -5,151,000 | 16,231,000 | 8,254,000 | 7,977,000 | -6,152,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.56
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NVNO | enVVeno Medical Corp | $6.02M | $8.67 | — |
| MHUAF | Meihua International Medical Technologies Co., Ltd. | $5.99M | $7.00 | — |
| ICCM | IceCure Medical Ltd. | $5.93M | $1.73 | — |
| INBS | INTELLIGENT BIO SOLUTIONS INC. | $5.15M | $1.70 | — |
| CODX | Co-Diagnostics, Inc. | $7.61M | $1.09 | — |
News headlines (Yahoo Finance, 1h cache)
Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA
2026-08-06 13:00 · Yahoo
Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution
2026-06-30 13:00 · Yahoo
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results
2026-06-16 20:15 · Yahoo
Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering
2026-04-24 13:21 · Yahoo
Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart
2026-03-24 12:30 · Yahoo
Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin
2026-03-18 12:30 · Yahoo
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results
2026-02-10 21:10 · Yahoo
Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf
2025-11-06 21:01 · Yahoo
Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals
2025-10-14 12:30 · Yahoo
Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA
2025-10-07 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.